http://www.mypharma-editions.com L'Info Industrie & Politique de Santé Wed, 15 Feb 2012 14:04:44 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents#comments Wed, 15 Feb 2012 08:30:40 +0000 morgdave http://www.mypharma-editions.com/?p=23431 http://www.mypharma-editions.com/des-instituts-europeens-de-recherche-sallient-contre-les-virus-emergents/feed 0 http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques#comments Tue, 14 Feb 2012 09:04:04 +0000 morgdave http://www.mypharma-editions.com/?p=23421 http://www.mypharma-editions.com/supercalculateur-curie-vers-de-nouvelles-pistes-therapeutiques/feed 0 http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros#comments Mon, 13 Feb 2012 15:06:12 +0000 morgdave http://www.mypharma-editions.com/?p=23410 http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros/feed 0 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad#comments Mon, 13 Feb 2012 09:50:44 +0000 morgdave http://www.mypharma-editions.com/?p=23407 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad/feed 0 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing#comments Mon, 13 Feb 2012 08:59:20 +0000 morgdave http://www.mypharma-editions.com/?p=23403 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing/feed 0 http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise#comments Fri, 10 Feb 2012 12:50:24 +0000 morgdave http://www.mypharma-editions.com/?p=23397 http://www.mypharma-editions.com/vaccin-contre-la-dengue-un-anticorps-prometteur-caracterise/feed 0 http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme#comments Fri, 10 Feb 2012 08:46:00 +0000 morgdave http://www.mypharma-editions.com/?p=23390 http://www.mypharma-editions.com/de-nouveaux-resultats-soulignent-limportance-des-genes-synaptiques-dans-lautisme/feed 0 http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans#comments Thu, 09 Feb 2012 08:54:37 +0000 morgdave http://www.mypharma-editions.com/?p=23374 http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans/feed 0 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche#comments Thu, 09 Feb 2012 08:30:20 +0000 morgdave http://www.mypharma-editions.com/?p=23372 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche/feed 0 http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil#comments Tue, 07 Feb 2012 10:11:48 +0000 morgdave http://www.mypharma-editions.com/?p=23345 http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil/feed 0 http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise#comments Fri, 03 Feb 2012 12:42:35 +0000 morgdave http://www.mypharma-editions.com/?p=23328 http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise/feed 0 http://www.mypharma-editions.com/e-sante-30-des-francais-recherchent-des-informations-medicales-sur-internet http://www.mypharma-editions.com/e-sante-30-des-francais-recherchent-des-informations-medicales-sur-internet#comments Fri, 03 Feb 2012 10:15:44 +0000 morgdave http://www.mypharma-editions.com/?p=23325 http://www.mypharma-editions.com/e-sante-30-des-francais-recherchent-des-informations-medicales-sur-internet/feed 0 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib#comments Thu, 02 Feb 2012 09:05:11 +0000 morgdave http://www.mypharma-editions.com/?p=23309 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib/feed 0 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle#comments Wed, 01 Feb 2012 15:55:41 +0000 morgdave http://www.mypharma-editions.com/?p=23306 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle/feed 0 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer#comments Wed, 01 Feb 2012 08:56:03 +0000 morgdave http://www.mypharma-editions.com/?p=23288 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause#comments Mon, 30 Jan 2012 15:21:25 +0000 morgdave http://www.mypharma-editions.com/?p=23254 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause/feed 0 http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement#comments Mon, 30 Jan 2012 10:03:28 +0000 morgdave http://www.mypharma-editions.com/?p=23240 http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement/feed 0 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012#comments Sat, 28 Jan 2012 08:38:42 +0000 morgdave http://www.mypharma-editions.com/?p=23233 http://www.mypharma-editions.com/emploi-linra-recrute-51-chercheurs-en-2012/feed 0 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340#comments Thu, 26 Jan 2012 09:27:02 +0000 morgdave http://www.mypharma-editions.com/?p=23210 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340/feed 0 http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r#comments Wed, 25 Jan 2012 17:39:13 +0000 morgdave http://www.mypharma-editions.com/?p=23202 http://www.mypharma-editions.com/pascale-briand-nommee-nouvelle-directrice-generale-de-la-n-r/feed 1 http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet#comments Wed, 25 Jan 2012 14:18:17 +0000 morgdave http://www.mypharma-editions.com/?p=23198 http://www.mypharma-editions.com/grippenet-fr-un-nouveau-systeme-de-surveillance-de-la-grippe-sur-internet/feed 0 http://www.mypharma-editions.com/le-fonds-mondial-nomme-gabriel-jaramillo-directeur-general http://www.mypharma-editions.com/le-fonds-mondial-nomme-gabriel-jaramillo-directeur-general#comments Wed, 25 Jan 2012 11:08:38 +0000 morgdave http://www.mypharma-editions.com/?p=23194 http://www.mypharma-editions.com/le-fonds-mondial-nomme-gabriel-jaramillo-directeur-general/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires#comments Wed, 25 Jan 2012 08:43:54 +0000 morgdave http://www.mypharma-editions.com/?p=23183 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires/feed 0 http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos#comments Tue, 24 Jan 2012 10:22:01 +0000 morgdave http://www.mypharma-editions.com/?p=23169 http://www.mypharma-editions.com/maladies-infectieuses-et-parasitaires-inauguration-de-linstitut-pasteur-du-laos/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique#comments Mon, 23 Jan 2012 17:22:09 +0000 morgdave http://www.mypharma-editions.com/?p=23158 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique/feed 0 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite#comments Mon, 23 Jan 2012 14:37:42 +0000 morgdave http://www.mypharma-editions.com/?p=23150 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite/feed 0 http://www.mypharma-editions.com/medicaments-dispositifs-medicaux-un-guide-de-la-has-sur-les-etudes-post-inscription http://www.mypharma-editions.com/medicaments-dispositifs-medicaux-un-guide-de-la-has-sur-les-etudes-post-inscription#comments Mon, 23 Jan 2012 14:09:25 +0000 morgdave http://www.mypharma-editions.com/?p=23142 http://www.mypharma-editions.com/medicaments-dispositifs-medicaux-un-guide-de-la-has-sur-les-etudes-post-inscription/feed 0 http://www.mypharma-editions.com/mediator-letude-reflex-va-suivre-1000-patients-atteints-de-valvulopathie http://www.mypharma-editions.com/mediator-letude-reflex-va-suivre-1000-patients-atteints-de-valvulopathie#comments Mon, 23 Jan 2012 09:16:52 +0000 morgdave http://www.mypharma-editions.com/?p=23133 http://www.mypharma-editions.com/mediator-letude-reflex-va-suivre-1000-patients-atteints-de-valvulopathie/feed 5 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012#comments Fri, 20 Jan 2012 13:08:17 +0000 morgdave http://www.mypharma-editions.com/?p=23108 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012/feed 0 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011#comments Fri, 20 Jan 2012 12:48:41 +0000 morgdave http://www.mypharma-editions.com/?p=23104 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011/feed 0 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation#comments Fri, 20 Jan 2012 12:44:05 +0000 morgdave http://www.mypharma-editions.com/?p=23100 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation/feed 0 http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes#comments Fri, 20 Jan 2012 12:04:54 +0000 morgdave http://www.mypharma-editions.com/?p=23098 http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes/feed 0 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts#comments Fri, 20 Jan 2012 09:07:59 +0000 morgdave http://www.mypharma-editions.com/?p=23087 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts/feed 0 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc#comments Thu, 19 Jan 2012 13:22:46 +0000 morgdave http://www.mypharma-editions.com/?p=23082 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc/feed 0 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns#comments Thu, 19 Jan 2012 09:11:07 +0000 morgdave http://www.mypharma-editions.com/?p=23078 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns/feed 0 http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon#comments Wed, 18 Jan 2012 10:09:20 +0000 morgdave http://www.mypharma-editions.com/?p=23055 http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon/feed 0 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique#comments Tue, 17 Jan 2012 14:40:00 +0000 morgdave http://www.mypharma-editions.com/?p=23037 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique/feed 0 http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france#comments Tue, 17 Jan 2012 08:41:55 +0000 morgdave http://www.mypharma-editions.com/?p=23031 http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france/feed 0 http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie#comments Tue, 17 Jan 2012 08:32:34 +0000 morgdave http://www.mypharma-editions.com/?p=23029 http://www.mypharma-editions.com/therapie-genique-resultats-encourageants-pour-la-gamma-sarcoglycanopathie/feed 0 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle#comments Mon, 16 Jan 2012 16:53:08 +0000 morgdave http://www.mypharma-editions.com/?p=23025 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle/feed 0 http://www.mypharma-editions.com/hepatites-virales-b-et-c-la-has-precise-sa-recommandation-sur-le-depistage http://www.mypharma-editions.com/hepatites-virales-b-et-c-la-has-precise-sa-recommandation-sur-le-depistage#comments Mon, 16 Jan 2012 12:46:09 +0000 morgdave http://www.mypharma-editions.com/?p=23018 http://www.mypharma-editions.com/hepatites-virales-b-et-c-la-has-precise-sa-recommandation-sur-le-depistage/feed 0 http://www.mypharma-editions.com/poliomyelite-aucun-cas-enregistre-depuis-un-an-en-inde http://www.mypharma-editions.com/poliomyelite-aucun-cas-enregistre-depuis-un-an-en-inde#comments Mon, 16 Jan 2012 09:41:15 +0000 morgdave http://www.mypharma-editions.com/?p=23012 http://www.mypharma-editions.com/poliomyelite-aucun-cas-enregistre-depuis-un-an-en-inde/feed 0 http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche#comments Thu, 12 Jan 2012 13:46:10 +0000 morgdave http://www.mypharma-editions.com/?p=22994 http://www.mypharma-editions.com/lafssaps-lance-un-premier-appel-a-projets-de-recherche/feed 1 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros#comments Thu, 12 Jan 2012 13:38:29 +0000 morgdave http://www.mypharma-editions.com/?p=22990 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros/feed 0 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012#comments Thu, 12 Jan 2012 08:38:50 +0000 morgdave http://www.mypharma-editions.com/?p=22986 http://www.mypharma-editions.com/lanrs-est-devenue-une-agence-autonome-de-linserm-depuis-le-1er-janvier-2012/feed 1 http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie#comments Wed, 11 Jan 2012 09:00:29 +0000 morgdave http://www.mypharma-editions.com/?p=22973 http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie/feed 0 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche#comments Tue, 10 Jan 2012 17:54:17 +0000 morgdave http://www.mypharma-editions.com/?p=22969 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche/feed 0 http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique#comments Tue, 10 Jan 2012 13:35:15 +0000 morgdave http://www.mypharma-editions.com/?p=22955 http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique/feed 0 http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans#comments Fri, 06 Jan 2012 09:25:40 +0000 morgdave http://www.mypharma-editions.com/?p=22936 http://www.mypharma-editions.com/le-declin-cognitif-apparaitrait-des-45-ans/feed 1 http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures#comments Fri, 06 Jan 2012 09:17:46 +0000 morgdave http://www.mypharma-editions.com/?p=22933 http://www.mypharma-editions.com/inserm-anne-bisagni-nommee-directrice-deleguee-aupres-de-la-presidence-et-de-claire-giry-directrice-du-departement-des-partenariats-et-des-relations-exterieures/feed 0 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs#comments Thu, 05 Jan 2012 08:27:09 +0000 morgdave http://www.mypharma-editions.com/?p=22929 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs/feed 1 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2#comments Thu, 05 Jan 2012 07:58:45 +0000 morgdave http://www.mypharma-editions.com/?p=22926 http://www.mypharma-editions.com/maladie-de-parkinson-oncodesign-et-ipsen-vont-developper-de-nouveaux-agents-therapeutiques-contre-la-cible-lrrk2/feed 1 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee#comments Tue, 03 Jan 2012 17:03:35 +0000 morgdave http://www.mypharma-editions.com/?p=22908 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee/feed 0 http://www.mypharma-editions.com/parution-au-journal-officiel-des-decrets-relatifs-au-developpement-professionnel-continu-dpc-des-professionnels-de-sante http://www.mypharma-editions.com/parution-au-journal-officiel-des-decrets-relatifs-au-developpement-professionnel-continu-dpc-des-professionnels-de-sante#comments Mon, 02 Jan 2012 14:09:21 +0000 morgdave http://www.mypharma-editions.com/?p=22903 http://www.mypharma-editions.com/parution-au-journal-officiel-des-decrets-relatifs-au-developpement-professionnel-continu-dpc-des-professionnels-de-sante/feed 0 http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez#comments Thu, 22 Dec 2011 16:09:05 +0000 morgdave http://www.mypharma-editions.com/?p=22892 http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez/feed 0 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises#comments Thu, 22 Dec 2011 10:21:24 +0000 morgdave http://www.mypharma-editions.com/?p=22870 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises/feed 0 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee#comments Tue, 20 Dec 2011 09:07:11 +0000 morgdave http://www.mypharma-editions.com/?p=22826 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee/feed 0 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011#comments Mon, 19 Dec 2011 15:42:54 +0000 morgdave http://www.mypharma-editions.com/?p=22821 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011/feed 0 http://www.mypharma-editions.com/vih-le-test-de-depistage-de-roche-pour-lhypersensibilite-a-labacavir-disponible-en-europe http://www.mypharma-editions.com/vih-le-test-de-depistage-de-roche-pour-lhypersensibilite-a-labacavir-disponible-en-europe#comments Mon, 19 Dec 2011 09:51:29 +0000 morgdave http://www.mypharma-editions.com/?p=22811 http://www.mypharma-editions.com/vih-le-test-de-depistage-de-roche-pour-lhypersensibilite-a-labacavir-disponible-en-europe/feed 0 http://www.mypharma-editions.com/allaitement-lafssaps-met-en-garde-contre-lutilisation-hors-amm-du-motilium http://www.mypharma-editions.com/allaitement-lafssaps-met-en-garde-contre-lutilisation-hors-amm-du-motilium#comments Mon, 19 Dec 2011 08:44:02 +0000 morgdave http://www.mypharma-editions.com/?p=22808 http://www.mypharma-editions.com/allaitement-lafssaps-met-en-garde-contre-lutilisation-hors-amm-du-motilium/feed 0 http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf#comments Fri, 16 Dec 2011 13:38:16 +0000 morgdave http://www.mypharma-editions.com/?p=22799 http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf/feed 0 http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat#comments Fri, 16 Dec 2011 09:33:46 +0000 morgdave http://www.mypharma-editions.com/?p=22795 http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat/feed 0 http://www.mypharma-editions.com/maladie-dalzheimer-nouvelle-recommandation-de-la-has-pour-le-diagnostic-et-la-prise-en-charge http://www.mypharma-editions.com/maladie-dalzheimer-nouvelle-recommandation-de-la-has-pour-le-diagnostic-et-la-prise-en-charge#comments Fri, 16 Dec 2011 08:19:55 +0000 morgdave http://www.mypharma-editions.com/?p=22791 http://www.mypharma-editions.com/maladie-dalzheimer-nouvelle-recommandation-de-la-has-pour-le-diagnostic-et-la-prise-en-charge/feed 0 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes#comments Thu, 15 Dec 2011 17:21:10 +0000 morgdave http://www.mypharma-editions.com/?p=22787 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes/feed 0 http://www.mypharma-editions.com/vih-reyataz-de-bms-autorise-chez-la-femme-enceinte-dans-lue http://www.mypharma-editions.com/vih-reyataz-de-bms-autorise-chez-la-femme-enceinte-dans-lue#comments Wed, 14 Dec 2011 11:06:03 +0000 morgdave http://www.mypharma-editions.com/?p=22758 http://www.mypharma-editions.com/vih-reyataz-de-bms-autorise-chez-la-femme-enceinte-dans-lue/feed 1 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques#comments Wed, 14 Dec 2011 08:55:28 +0000 morgdave http://www.mypharma-editions.com/?p=22752 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques/feed 0 http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla#comments Tue, 13 Dec 2011 10:00:22 +0000 morgdave http://www.mypharma-editions.com/?p=22717 http://www.mypharma-editions.com/trophos-echec-de-l%e2%80%99olesoxime-dans-un-essai-de-phase-iii-dans-la-sla/feed 0 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur#comments Tue, 13 Dec 2011 09:24:24 +0000 morgdave http://www.mypharma-editions.com/?p=22712 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur/feed 0 http://www.mypharma-editions.com/alzheimer-exonhit-lance-une-etude-observationnelle-sur-son-test-aclarusdx%c2%ae-en-france http://www.mypharma-editions.com/alzheimer-exonhit-lance-une-etude-observationnelle-sur-son-test-aclarusdx%c2%ae-en-france#comments Tue, 13 Dec 2011 07:42:47 +0000 morgdave http://www.mypharma-editions.com/?p=22703 http://www.mypharma-editions.com/alzheimer-exonhit-lance-une-etude-observationnelle-sur-son-test-aclarusdx%c2%ae-en-france/feed 0 http://www.mypharma-editions.com/le-dr-claude-leicher-reconduit-a-la-tete-du-syndicat-mg-france http://www.mypharma-editions.com/le-dr-claude-leicher-reconduit-a-la-tete-du-syndicat-mg-france#comments Mon, 12 Dec 2011 15:49:54 +0000 morgdave http://www.mypharma-editions.com/?p=22698 http://www.mypharma-editions.com/le-dr-claude-leicher-reconduit-a-la-tete-du-syndicat-mg-france/feed 0 http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple#comments Mon, 12 Dec 2011 13:28:21 +0000 morgdave http://www.mypharma-editions.com/?p=22689 http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple/feed 0 http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir#comments Mon, 12 Dec 2011 08:41:53 +0000 morgdave http://www.mypharma-editions.com/?p=22677 http://www.mypharma-editions.com/vih-gilead-annonce-les-donnees-sur-deux-ans-dune-etude-pivot-de-phase-3-sur-lelvitegravir/feed 1 http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash#comments Mon, 12 Dec 2011 08:28:21 +0000 morgdave http://www.mypharma-editions.com/?p=22669 http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash/feed 0 http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash#comments Mon, 12 Dec 2011 08:22:44 +0000 morgdave http://www.mypharma-editions.com/?p=22667 http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash/feed 0 http://www.mypharma-editions.com/le-syndicat-des-ophtalmologistes-pour-un-regroupement-avec-les-orthoptistes http://www.mypharma-editions.com/le-syndicat-des-ophtalmologistes-pour-un-regroupement-avec-les-orthoptistes#comments Fri, 09 Dec 2011 14:17:31 +0000 morgdave http://www.mypharma-editions.com/?p=22654 http://www.mypharma-editions.com/le-syndicat-des-ophtalmologistes-pour-un-regroupement-avec-les-orthoptistes/feed 0 http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche#comments Thu, 08 Dec 2011 07:59:52 +0000 morgdave http://www.mypharma-editions.com/?p=22626 http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche/feed 0 http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi#comments Thu, 08 Dec 2011 07:40:15 +0000 morgdave http://www.mypharma-editions.com/?p=22623 http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi/feed 0 http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne#comments Tue, 06 Dec 2011 16:30:46 +0000 morgdave http://www.mypharma-editions.com/?p=22611 http://www.mypharma-editions.com/la-vaccination-antigrippale-h1n1-protege-a-la-fois-la-femme-enceinte-et-le-nouveau-ne/feed 0 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche#comments Tue, 06 Dec 2011 16:13:51 +0000 morgdave http://www.mypharma-editions.com/?p=22608 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche/feed 0 http://www.mypharma-editions.com/echographies-commerciales-les-gynecologues-mettent-en-garde http://www.mypharma-editions.com/echographies-commerciales-les-gynecologues-mettent-en-garde#comments Tue, 06 Dec 2011 12:18:43 +0000 morgdave http://www.mypharma-editions.com/?p=22596 http://www.mypharma-editions.com/echographies-commerciales-les-gynecologues-mettent-en-garde/feed 0 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi#comments Tue, 06 Dec 2011 08:59:53 +0000 morgdave http://www.mypharma-editions.com/?p=22587 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi/feed 0 http://www.mypharma-editions.com/vih-le-cobicistat-de-gilead-atteint-son-objectif-principal-lors-dune-etude-decisive-de-phase-3 http://www.mypharma-editions.com/vih-le-cobicistat-de-gilead-atteint-son-objectif-principal-lors-dune-etude-decisive-de-phase-3#comments Tue, 06 Dec 2011 08:20:44 +0000 morgdave http://www.mypharma-editions.com/?p=22581 http://www.mypharma-editions.com/vih-le-cobicistat-de-gilead-atteint-son-objectif-principal-lors-dune-etude-decisive-de-phase-3/feed 0 http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis#comments Fri, 02 Dec 2011 15:18:49 +0000 morgdave http://www.mypharma-editions.com/?p=22566 http://www.mypharma-editions.com/claude-bertrand-nomme-president-d%e2%80%99ariis/feed 0 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes#comments Thu, 01 Dec 2011 13:39:05 +0000 morgdave http://www.mypharma-editions.com/?p=22542 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes/feed 0 http://www.mypharma-editions.com/vihsida-l%e2%80%99industrie-pharmaceutique-mobilisee-pour-la-recherche-de-nouveaux-traitements http://www.mypharma-editions.com/vihsida-l%e2%80%99industrie-pharmaceutique-mobilisee-pour-la-recherche-de-nouveaux-traitements#comments Thu, 01 Dec 2011 09:48:20 +0000 morgdave http://www.mypharma-editions.com/?p=22530 http://www.mypharma-editions.com/vihsida-l%e2%80%99industrie-pharmaceutique-mobilisee-pour-la-recherche-de-nouveaux-traitements/feed 0 http://www.mypharma-editions.com/vihsida-une-campagne-dincitation-au-depistage-en-france http://www.mypharma-editions.com/vihsida-une-campagne-dincitation-au-depistage-en-france#comments Thu, 01 Dec 2011 09:36:15 +0000 morgdave http://www.mypharma-editions.com/?p=22527 http://www.mypharma-editions.com/vihsida-une-campagne-dincitation-au-depistage-en-france/feed 0 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011#comments Wed, 30 Nov 2011 08:41:07 +0000 morgdave http://www.mypharma-editions.com/?p=22512 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011/feed 1 http://www.mypharma-editions.com/vih-gilead-recoit-une-amm-europeenne-pour-eviplera%c2%ae http://www.mypharma-editions.com/vih-gilead-recoit-une-amm-europeenne-pour-eviplera%c2%ae#comments Wed, 30 Nov 2011 08:09:12 +0000 morgdave http://www.mypharma-editions.com/?p=22507 http://www.mypharma-editions.com/vih-gilead-recoit-une-amm-europeenne-pour-eviplera%c2%ae/feed 0 http://www.mypharma-editions.com/vih-sida-un-nombre-stable-de-nouveaux-cas-en-france http://www.mypharma-editions.com/vih-sida-un-nombre-stable-de-nouveaux-cas-en-france#comments Tue, 29 Nov 2011 14:50:30 +0000 morgdave http://www.mypharma-editions.com/?p=22500 http://www.mypharma-editions.com/vih-sida-un-nombre-stable-de-nouveaux-cas-en-france/feed 0 http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca#comments Mon, 28 Nov 2011 13:31:46 +0000 morgdave http://www.mypharma-editions.com/?p=22494 http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca/feed 0 http://www.mypharma-editions.com/medecine-xavier-bertrand-annonce-une-hausse-du-numerus-clausus http://www.mypharma-editions.com/medecine-xavier-bertrand-annonce-une-hausse-du-numerus-clausus#comments Sat, 26 Nov 2011 16:09:21 +0000 morgdave http://www.mypharma-editions.com/?p=22483 http://www.mypharma-editions.com/medecine-xavier-bertrand-annonce-une-hausse-du-numerus-clausus/feed 0 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505#comments Sat, 26 Nov 2011 08:59:59 +0000 morgdave http://www.mypharma-editions.com/?p=22480 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505/feed 0 http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat#comments Fri, 25 Nov 2011 08:08:48 +0000 morgdave http://www.mypharma-editions.com/?p=22474 http://www.mypharma-editions.com/cellectis-et-lefs-vont-inaugurer-leur-partenariat/feed 0 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo#comments Wed, 23 Nov 2011 16:52:55 +0000 morgdave http://www.mypharma-editions.com/?p=22457 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo/feed 0 http://www.mypharma-editions.com/pharmacovigilance-prescrire-propose-un-manuel-de-formation-en-ligne http://www.mypharma-editions.com/pharmacovigilance-prescrire-propose-un-manuel-de-formation-en-ligne#comments Wed, 23 Nov 2011 16:01:04 +0000 morgdave http://www.mypharma-editions.com/?p=22451 http://www.mypharma-editions.com/pharmacovigilance-prescrire-propose-un-manuel-de-formation-en-ligne/feed 0 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement#comments Wed, 23 Nov 2011 09:28:29 +0000 morgdave http://www.mypharma-editions.com/?p=22443 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement/feed 0 http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce#comments Tue, 22 Nov 2011 09:26:44 +0000 morgdave http://www.mypharma-editions.com/?p=22421 http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce/feed 0 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2#comments Tue, 22 Nov 2011 08:59:50 +0000 morgdave http://www.mypharma-editions.com/?p=22418 http://www.mypharma-editions.com/pharnext-termine-le-recrutement-pour-son-essai-clinique-de-phase-ii-avec-son-1er-pleomedicament%e2%84%a2/feed 0 http://www.mypharma-editions.com/34-millions-de-personnes-vivent-avec-le-vih-selon-le-rapport-onusida-2011 http://www.mypharma-editions.com/34-millions-de-personnes-vivent-avec-le-vih-selon-le-rapport-onusida-2011#comments Mon, 21 Nov 2011 10:16:04 +0000 morgdave http://www.mypharma-editions.com/?p=22401 http://www.mypharma-editions.com/34-millions-de-personnes-vivent-avec-le-vih-selon-le-rapport-onusida-2011/feed 0 http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals#comments Thu, 17 Nov 2011 08:39:05 +0000 morgdave http://www.mypharma-editions.com/?p=22333 http://www.mypharma-editions.com/traitement-anti-vih-gilead-sciences-finalise-un-accord-avec-tibotec-pharmaceuticals/feed 1